14 September 2023
14 September 2023
The FDA has granted 510(k) clearance and breakthrough device designation to the company’s obstructive hydrocephalus CT scan software.
Belong.Life launches its matching platform to connect cancer patients with clinical trials to access potentially life-saving treatment.
The system helps surgeons better control C-arm positioning during surgical procedures.
New research, utilising artificial intelligence to track the diversion of drugs in medical settings, has found more than half of its users are confident in their ability to keep track of their medicines
The company has shown the efficacy and safety of the system through clinical studies in breast biopsy.
The FULCRUM-VT trial will enrol 20 patients across four investigational sites.
The funding will help make essential improvements to the ultraportable PD device for the final pivotal trial in the US.
The patch allows for vaccine storage and transport at room temperature, along with at-home administration.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Generative AI can improve personalized healthcare by collecting data from patients via wearable devices, which can provide continuous, real-time data that can complement traditional data sources such as imaging, patient records, and more. It can also enhance existing imaging techniques by generating high-quality images of organs using data from low-resolution images (such as ultrasounds). However, the collection and use of patient healthcare data through AI medical products could conflict with regulations around the globe.
Give your business an edge with our leading industry insights.
